Amer Saad Alali

Pharmacology, Toxicology and Pharmaceutical Science

1. Breast Cancer 100%
2. Chitosan 98%
3. Rheumatoid Arthritis 73%
4. Inflammatory Arthritis 73%
5. Pharmacokinetic 71%
6. Erectile Dysfunction 65%
7. Ethyl Cellulose 65%
8. Bioavailability 59%
9. Cytotoxicity 54%
10. Diseases 52%
11. Drug Release 46%
12. Zeta Potential 44%
13. Egg Lecithin 40%
14. Nanoparticle 40%
15. Tablet 40%
16. Systemic Lupus Erythematosus 40%
17. Cohort Study 39%
18. Comorbidity 38%
19. Microcrystalline Cellulose 38%
20. Lung Cancer 38%
21. Rat Model 37%
22. Dyspnea 36%
23. Chronic Kidney Failure 34%
24. Coronavirinae 32%
25. Drug Dose 32%
26. Glycyrrhizin 32%
27. Sunitinib 32%
28. Vitamin D 32%
29. Silicon Dioxide 32%
30. Nanoemulsion 32%
31. Disease Model 32%
32. Cerebrovascular Accident 32%
33. Nanofiber 32%
34. Hydroxychloroquine 32%
35. Olaparib 32%
36. Neoplasm 32%
37. Tableting 32%
38. Macrogol 32%
39. Apigenin 32%
40. Tadalafil 32%
41. Curcumin 32%
42. Wound Healing 32%
43. Liposome 32%
44. Sildenafil 32%
45. Drug Delivery System 32%
46. Anti-Inflammatory Drug 32%
47. Chitosan Nanoparticle 32%
48. Diarrhea 32%
49. Captopril 32%
50. Formulation Design 32%